We use essential cookies (authentication, your saved goals/stack) by default. With your permission we'll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more about cookies
Soy Peptides (soy protein hydrolysate bioactive peptides; incl. lunasin)
Short, bioactive fragments enzymatically cleaved from soy protein — soy protein hydrolysates plus named peptides like lunasin and soy ACE-inhibitory peptides. Unlike whole soy protein (a complete protein with an FDA cholesterol claim) or soy isoflavones (phytoestrogens), these are specific peptide fragments studied for cholesterol, blood pressure and antioxidant effects. Honest appraisal: the evidence is mostly in-vitro and animal. The one published human RCT (lunasin) was null. Emerging, not established.
What the evidence says
Most Soy Peptides studies are mechanism or observational rather than RCTs that measure a clinical effect — keep findings provisional.
Most evidence is from mixed-quality randomised trials published 2007–2022 with a typical study size of 31 participants.
Based on 11 studies · 1 RCT · 31 total participants
Confidence
LowBy outcome
Soy Peptides has an evidence score of 3/10 — emerging evidence based on 11 indexed studies. Short, bioactive fragments enzymatically cleaved from soy protein — soy protein hydrolysates plus named peptides like lunasin and soy ACE-inhibitory peptides. Unlike whole soy protein (a complete protein with an FDA cholesterol claim) or soy isoflavones (phytoestrogens), these are specific peptide fragments studied for cholesterol, blood pressure and antioxidant effects. Honest appraisal: the evidence is mostly in-vitro and animal. The one published human RCT (lunasin) was null. Emerging, not established. Representative study: PMID 36461277.
The commonly studied dose of Soy Peptides is No validated human dose. The single lunasin RCT used 335 mg/day of lunasin-enriched soy extract; soy protein hydrolysate ingredients are typically used at ~1-6 g/day, but no efficacious human regimen is established.. Individual needs vary — start at the lower end of the range and adjust based on how you respond.
Explore: Best supplements for Vitality & Longevity
Last reviewed June 2026 · evidence from 11 studies · how we score
This information is for educational purposes only. It is not a substitute for professional medical advice. Always consult a qualified healthcare provider before starting, stopping, or changing any supplement or medication.
Mechanisms for cholesterol, blood-pressure, and antioxidant effects are well-characterized in cell and enzyme models, but the single published human RCT was null, keeping evidence Emerging.
Soy peptides are short amino-acid sequences released from soy (Glycine max) protein by enzymatic hydrolysis, fermentation, or gastrointestinal digestion.
This entry is specifically about those bioactive *peptide fragments* — soy protein hydrolysates and named peptides such as lunasin (a 43-amino-acid seed peptide) and soy ACE-inhibitory peptides — and is deliberately distinct from the site's separate 'soy protein' entry (whole, intact protein dosed in grams for muscle and cholesterol, carrying the FDA heart-health claim) and 'soy isoflavones' entry (phytoestrogen non-protein compounds).
Critically, the bioactive-peptide fraction is largely separable from isoflavones: one mechanistic study explicitly showed that an isoflavone-containing ethanol extract did NOT stimulate LDL-receptor transcription, whereas the peptide fraction did — so isolated soy peptides carry a low estrogenic load compared with whole soy.
The proposed mechanisms are plausible and well-characterized in the dish: soy peptides inhibit angiotensin-converting enzyme (ACE) in vitro (suggesting a blood-pressure angle), up-regulate hepatic LDL-receptor transcription (a hypocholesterolemic angle distinct from isoflavones), and scavenge free radicals / reduce reactive oxygen species (an antioxidant angle).
Lunasin specifically has antioxidant, anti-inflammatory, and endothelial-protective effects in cell and animal models. But the honest evidence picture is thin and front-loaded with preclinical work.
The single published human trial — a triple-blind placebo-controlled crossover of lunasin-enriched soy extract (335 mg/day, 8 weeks) in 31 adults — found NO significant change in cholesterol, glucose, insulin, blood pressure, or body composition, and its authors called for higher doses and larger samples.
Most of the cholesterol, blood-pressure, and antioxidant claims therefore rest on cell, enzyme-assay, and rodent data, not on controlled human outcomes. The overall evidence is emerging.
Soy protein hydrolysate fractions and lunasin-derived fragments inhibit angiotensin-converting enzyme in enzyme assays (e.g. the peptide NDRP, IC50 ~148 μg/mL), the same target class as antihypertensive drugs — but this is shown in vitro, not yet in human blood-pressure trials.
Soybean protein hydrolysate peptides stimulate hepatic LDL-receptor (LDL-R) transcription in liver-cell models, a cholesterol-clearance mechanism. Notably the isoflavone-containing fraction did NOT do this — the activity tracks the peptides, distinguishing it from soy isoflavones.
Lunasin and soy peptide fractions scavenge peroxyl, superoxide, DPPH and ABTS radicals and reduce reactive oxygen species in cell models, protecting against oxidative damage in vitro.
In cell models lunasin suppresses ox-LDL-induced monocyte adhesion to endothelial cells (via KLF2/eNOS) and dampens NF-κB inflammatory signalling — an early-atherosclerosis-relevant mechanism, but entirely preclinical.
How Soy Peptides works — from molecular targets to health outcomes. Click an edge to see supporting research.This visualization is in beta — pathways are being refined and expanded.
Tap node to isolate • Pinch to zoom • Tap edge for research
No validated human dose. The single lunasin RCT used 335 mg/day of lunasin-enriched soy extract; soy protein hydrolysate ingredients are typically used at ~1-6 g/day, but no efficacious human regimen is established.
Take with food
| Form | Type |
|---|---|
| 💊Soy protein hydrolysate | Recommended |
| 💊Lunasin-enriched soy extract | Alternative |
Distinct from whole soy protein (dosed in grams for muscle/cholesterol) and soy isoflavones (phytoestrogens). The bioactive-peptide fraction carries a low isoflavone/estrogenic load.
Minimum: 4 weeks
Optimal: 8 weeks
Cycling: Not required
Note: Take with food; no validated timing. Bioavailability of intact peptides is a real limitation, not a solved problem.
Dose-response data unavailable. The current published research for Soy Peptides does not provide sufficient dose-specific outcome data to generate reliable dose-response curves.
Refer to the Dosage & Timing section above for recommended dose ranges based on available evidence.
An 8-week triple-blind crossover of lunasin-enriched soy extract (335 mg/day) found no significant change in cholesterol, glucose, insulin, blood pressure, or body composition.
Peptides up-regulate LDL-receptor transcription in liver cells; the human outcome data to back this up are not yet there.
Strong radical-scavenging and ROS-reducing activity in cell and chemical assays; not validated as a clinical antioxidant outcome.
As a food-protein-derived ingredient, soy peptides are generally well tolerated; the main concern is soy allergy.
Contraindicated — avoid entirely.
Generally safe; monitor blood pressure given the theoretical additive effect.
Soy as a food is part of normal diets; isolated soy-peptide supplements are not specifically studied in pregnancy. The isoflavone/estrogenic load of the isolated peptide fraction is low, so the food-derived peptides are likely safe at dietary-level intakes, but supplement-level data are lacking.
Soy peptides inhibit ACE in vitro; a theoretical additive blood-pressure-lowering effect with antihypertensive medication, though no clinically meaningful human interaction has been demonstrated.
Soy protein products can interfere with thyroid-hormone absorption; separate dosing if taken alongside soy-derived ingredients.
Tip: Avoid entirely if soy-allergic
Tip: Take with food; reduce dose
Tip: Inherent to protein hydrolysates; mask in food/beverage
The best time to take Soy Peptides is with meals. Take it with food. Food-derived peptides are typically taken with meals; no validated optimal schedule exists.
Soy Peptides is generally well-tolerated and considered safe for most healthy adults at recommended doses. The most commonly reported side effects are allergic reaction (in soy-allergic individuals), GI upset / bloating, bitter taste. Use caution if any of these apply to you: Soy allergy (absolute — soy is a major allergen); Known hypersensitivity to soy protein.
Activates AMPK to regulate blood sugar, improve insulin sensitivity, and support lipid metabolism — comparable to metformin in some trials.